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Abstract
Background: RNA interference (RNAi) is a cellular mechanism in which a short/small double
stranded RNA induces the degradation of its sequence specific target mRNA, leading to specific
gene silencing. Since its discovery, RNAi has become a powerful biological technique for gene
function studies and drug discovery. The very first requirement of applying RNAi is to design
functional small interfering RNA (siRNA) that can uniquely induce the degradation of the targeted
mRNA. It has been shown that many functional synthetic siRNAs share some common
characteristics, such as GC content limitation and free energy preferences at both terminals, etc.
Results: Our three-phase algorithm was developed to design siRNA on a whole-genome scale
based on those identified characteristics of functional siRNA. When this algorithm was applied to
design short hairpin RNA (shRNA), the validated success rate of shRNAs was over 70%, which was
almost double the rate reported for TRC library. This indicates that the designs of siRNA and
shRNA may share the same concerns. Further analysis of the shRNA dataset of 444 designs reveals
that the high free energy states of the two terminals have the largest positive impact on the shRNA
efficacy. Enforcing these energy characteristics of both terminals can further improve the shRNA
design success rate to 83.1%. We also found that functional shRNAs have less probability for their
3' terminals to be involved in mRNA secondary structure formation.
Conclusion: Functional shRNAs prefer high free energy states at both terminals. High free energy
states of the two terminals were found to be the largest positive impact factor on shRNA efficacy.
In addition, the accessibility of the 3' terminal is another key factor to shRNA efficacy.
Background
RNA interference (RNAi) is a cellular mechanism in which
a short/small double stranded RNA induces the degrada-
tion of its sequence specific target mRNA, leading to spe-
cific gene silencing. Since its discovery, RNAi has become
a powerful biological technique for gene function studies
and drug discovery [1-3]. It also shows promise as a direct
therapeutic agent [4-6]. In order to apply RNAi technol-
ogy, one must scan the target sequence and identify a
stretch of 19 ~29 nucleotide sequence that might give the
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best chance to succeed as gene-specific small interfering
RNA (siRNA) because randomly selected siRNA is seldom
functional [7]. Previous research has identified some
empirical rules regarding the efficacy of siRNA sequences.
These rules include the GC content limitation (the opti-
mal GC content is between 30% and 55%) [7-13], the
thermo-stability preference (lower stability at the 3' termi-
nal of sense strand would help the antisense strand enter
into the RISC complex) [11,14,15], and some base prefer-
ences in the siRNA sequences [7,16]. Recently, several
studies employed computational methods to analyze the
published functional siRNA datasets whose sizes are rela-
tively large and revealed more base preferences at particu-
lar positions [17-20]. These computational models and
their discoveries seem to be promising, because they were
using large set of experimentally validated sequences.
However, one must be cautious when reading into these
conclusions because the existing datasets might be biased
for lack of negative results (some negative results were sel-
dom reported in publications).
Another challenge is that most existing datasets are usu-
ally about chemically synthesized siRNA sequences. Cur-
rently there are two approaches to induce siRNA
sequences into cells. One is to transfect chemically synthe-
sized siRNA sequences into cells. Though this approach is
more frequently used, the drawback is that it can not offer
long-term gene suppression and some mammalian cell
types are resistant to the transfection methods [21,22].
The alternative approach is to have a small hairpin RNA or
short hairpin RNA (shRNA) expressed on a plasmid vector
that enables long-term gene suppression [22]. Another
advantage of using the shRNA approach is that once a
functional vector is identified, it can be reproduced easily
and inexpensively.
As suggested by Matveeva et al [19], some of the character-
istics of functional siRNA may not apply to shRNA,
though many of them may. In 2004 and 2005, we devel-
oped a three-phase algorithm for computer-aided siRNA
design [23,24]. This algorithm includes all the design con-
siderations published by then and arranges all the neces-
sary siRNA selection rules in three groups of filters
according to their impacts on the siRNA efficacy and
applies them to the design process in three steps. Each fil-
ter represents a specific design rule. Phase I filters elimi-
nate all the siRNA sequences containing the damaging
elements for a functional siRNA. Examples are those filters
that prohibit the existence of internal palindromes or long
GC stretches. All siRNA candidates must successfully pass
all the phase I filter assessment. Phase II filters are used to
rank eligible siRNA sequences by a final score with the
sum of gain and penalty points. There is a cutoff such that
siRNA candidates will be selected only if their final scores
are no less than the cutoff point. Phase III filters represent
those rules whose impact on the siRNA functionality has
yet to be clarified and therefore are considered optional.
Most of the selective filters in Phase II are set to ensure the
selection rule that the 3' terminal is less thermodynami-
cally stable, compared to the 5' end (on the sense strand).
This differential stability increases the probability that the
antisense strand will be incorporated into the RISC com-
plex [14,15]. This algorithm was adopted by SABio-
sciences Corporation and has been eventually used for
their shRNA design. Biological experiments conducted by
SABiosciences have shown that 71.2% (316/444) of the
shRNAs designed by our algorithm are functional (i.e. can
suppress at least 70% of the target gene expression in aver-
age), a high success rate that has never been reported
experimentally with shRNA (for the definition of a func-
tional shRNA or a successful design of shRNA, please read
the section Methods). For example, the design algorithms
employed recently by Root [22] and Moffat [21] for
shRNA generate less than 40% functional shRNAs. Since
our algorithm was originally developed based on discov-
eries and studies concerning siRNA functionality, its high
success rate in shRNA design suggests that most design
concerns for siRNA sequences are applicable to shRNA
design.
This article further extends our analysis on the available
shRNA dataset generated by SABiosciences. Although this
dataset is biased as it is specifically generated by our three-
phase algorithm, the analysis reveals useful information
that may help confirm the effectiveness of the rules used
in the algorithm, modify the existing rules or rearrange
them for better prediction and identify new rules.
Results and discussion
The two sets of biological experiments completely tested
444 shRNAs targeting 125 human genes. Of the 444 shR-
NAs, 316 are found to be functional (71.2%). Consider-
ing the fact that variations exist in the experimentally
measured suppression efficacy, we decided to remove
some shRNAs whose efficacy are in the range near 70% in
hope of ensuring the validity of the dataset. The two
ranges for removal are 60–75% and 55–80%. This means
we exclude shRNAs whose efficacy is between 60–75%
and 55–80% respectively. With the 60–75% removal
range, there are 351 shRNAs for analysis in which 268 are
considered functional (efficacy >= 75%). However, with
the 55–80% range, there are only 289 shRNA sequences
for analysis in which 221 shRNAs are considered func-
tional (efficacy >= 80%).
By default, the three-phase algorithm sets a selection cut-
off such that only shRNAs which score at least 7 points
will be selected for biological experiments. However,
former experiments showed that there were a few genes
for which our algorithm failed to design enough shRNAsBMC Genomics 2009, 10(Suppl 1):S9 http://www.biomedcentral.com/1471-2164/10/S1/S9
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[23]. Thus in the dataset there are some shRNAs scoring
less than 7 points. For this reason, the chi-square test for
independence, is first applied to assess if the 7-points-cut-
off is significant in distinguishing between functional and
nonfunctional shRNAs. Note that all further statistical
results are obtained using the chi-square test unless other-
wise noted. The analysis shows that the 7-points-cutoff is
significant in making the distinction between the func-
tional and nonfunctional shRNAs. shRNAs scoring at least
7 points have a higher probability of being functional.
When the removal range is 60–75%, the p-value is 0.037.
With the removal range to be 55–80%, the statistical sig-
nificance increases (p = 0.0046). Several other removal
ranges were tested using the chi-square test and it has been
found that the removal range of 55–80% generates the
most significant result. For example, if the removal range
is further expanded to be 50–85%, the significance drops
(p = 0.037). Unless otherwise stated, the rest of our results
were obtained with a removal range of 55–80%.
To obtain 7 points for a shRNA, it must pass multiple
phase II filters. What filters/rules contribute to the statisti-
cal bias of the 7-points-cutoff? After analyzing all the
design rules, we found that the shRNAs scoring no less
than 7 are perfectly correlated with the f-dga filter (R =
1.0). The f-dga filter in phase II is defined such that any
shRNA whose free energy (ΔG) of the 5-mer at 3' terminal
is no less than -3.2 would gain 1 point. The free energy of
the 5-mer at 3' terminal, ΔGas-5 (Subscript as in ΔGas-5 rep-
resents the 3' terminal while ss  represents the 5'
terminal,-5 means the first 5 nucleotides), shows some
bias between functional and nonfunctional shRNAs.
Functional shRNAs prefer the ΔGas-5 to be no less than -3.2
while disfavoring ΔGas-5 being less than -3.2 (p = 0.0046).
This shows that the statistical bias behind the 7-points-
cutoff is due to the ΔGas-5 values of shRNAs, and suggests
that having ΔGas-5 larger than -3.2 increases the probabil-
ity obtaining functional shRNAs at the expense of missing
some functional ones (shown in Table 1).
Table 1 indicates that the enforcement of filter f-dga in the
selection algorithm could improve the design success rate
significantly at the expense of missing some functional
shRNAs. The results in Table 1 were obtained using a
removal range of 55–80%. Even with no removal range,
enforcing the filter f-dga significantly improves the shRNA
design success rate to 76.0% (222 out of 292). This sug-
gests that the high energy state at the 3' terminal has pos-
itive impact on shRNA efficacy.
The free energy of 3' terminal is computed with the first 5
terminal base pairs as suggested by Ui-Tei and Levenkova
[12,25]. It is reasonable to ask if other base pair lengths
could better represent the free energy of the 3' terminal.
The free energies of different base pair lengths (2 to 10)
from both the 5' terminal and 3' terminal are computed
and chi-square test for independence is conducted to eval-
uate if there is any significant correlation between the free
energy values and the shRNA efficacies. It is found that the
free energy values of the first 6, 7 or 8 base pairs from 3'
terminal have statistically significant correlation with the
shRNA efficacy (p values are 0.0046, 0.0005 and 0.0011
respectively). Based on the p values, it looks like that
ΔGas-7 is a better representation of the free energy than
ΔGas-5. Also it is found that ΔGss-6 and ΔGss-7 show signifi-
cant correlation with shRNA efficacy (p values are
0.00447 and 0.00546 respectively). Making judgment
from the p values, it is not difficult to observe that the
high energy state at the 3' terminal (5' end of antisense
strand) can better differentiate functional and nonfunc-
tional shRNAs than the high energy state at the 5' terminal
(5' end of sense strand) can. This confirms the strand bias
discovered before [14,15]. However, it turns out that it is
more promising to use either ΔGas-7, ΔGss-6 or both to pre-
dict the efficacy of shRNAs. The above results are summa-
rized in Table 2. Our discovery differs from the recent
findings on siRNA made by Matveeva and Shabalina
[19,20]. Matveeva and Shabalina found that the ΔG of the
first and last two base pairs at the two terminals correlates
well with siRNA efficacy. The difference between our
results and theirs might be due to the fact that different
data sets were used or to the differences between chemi-
cally synthesized siRNAs and shRNAs.
Without any removal range, all the shRNAs whose ΔGas-7
>= -6.6 or ΔGss-6 >= -7.0 or both have averaged suppres-
sion efficacy of 76.98%, while those shRNAs with no high
energy state at either end have averaged suppression effi-
cacy of 65.83%. A two-sample t-test reveals that the differ-
ence between the two averaged efficacy is very significant
(p = 0.0000047). This confirms that the use of either
ΔGas-7, ΔGss-6or both could significantly improve the selec-
tion of functional shRNAs.
Recent research has shown that the siRNA sequence char-
acteristics could be helpful in predicting siRNA efficacy
[16-20]. To test this, we compiled a set of 404 sequence
Table 1: Higher ΔGas-5 increases the probability that shRNAs are 
functional.
shRNA ΔGas-5 Number Functional Rate
>= -3.2 Functional 155 81.6% (155/190)
Not functional 35
<-3.2 Functional 66 66.7% (66/99)
Not functional 33BMC Genomics 2009, 10(Suppl 1):S9 http://www.biomedcentral.com/1471-2164/10/S1/S9
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characteristics parameters and used linear least square
analysis (multiple regression analysis) in an effort to iden-
tify the most influential sequence characteristics. Since the
two terminals' energy profiles contribute to shRNA effi-
cacy, the least square analysis includes the two energy
parameters. The 406 parameters are generated as follows:
￿ The free energy of the first 7 base pairs of the antisense
string (if >= -6.6, then value 1; otherwise, value -1).
￿ The free energy of the first 6 base pairs of the sense string
(if >= -7.0, value equals 1; otherwise value equals -1).
￿ At each of the 21 positions, the nucleotide could be
either A, C, G, T. For the presence of each nucleotide, there
are 4 values generated. For example, for A, the 4 parame-
ters are 1 0 0 0 while for G they are 0 0 1 0. So there are 84
parameters for the 21 nucleotides.
￿ For each pair of nearest neighbors, there are 4 × 4 = 16
parameters. For example, for AC, they are 0 1 0 0 0 0 0 0
0 0 0 0 0 0 0 0. So there are 16 × 20 = 320 parameters.
For this analysis, the removal range of 60–75% was
selected since it provides a larger sample size than the
removal range 55–80%. For each round of linear square
analysis, three-fourth of shRNAs from the shRNA dataset
were randomly selected as the experimental group to
identify the best set of coefficients for the 406 parameters,
while the remaining one-fourth of the samples were used
to evaluate how well the parameters and the found coeffi-
cients can predict the shRNA efficacy. The experiment was
repeated 8 times. The averaged prediction accuracy is
about 68.55%, which cannot match the prediction by
only using the energy profiles. Nevertheless, the linear
analysis revealed that for the 8 repetitions of the experi-
ments, some parameters always showed significant posi-
tive impact on the shRNA efficacy while others always had
significant negative influence. These parameters are listed
in Table 3.
Different parameter sets are also compiled in search for
the best parameter set. For example, some parameter sets
exclude energy profiles and some include GC ratio, etc. It
is worthy to note that with different parameter sets, the
coefficients change dramatically while the predication
accuracy does not improve. This makes us wonder
whether the findings by linear least square analysis are
nuisances. However, we did notice that on average, the
nucleotide pairs have larger impact than single nucle-
otides. For example, in Table 3, the absolute average value
of the coefficients of pairs is 20.33 while that of the single
nucleotide is 7.73. The T-test shows that the p-value of the
Table 2: Using either ΔGas-7, ΔGss-6 or both can better predict the efficacy of shRNAs.
Energy profile ΔGas-5 ΔGas-7 ΔGss-6 ΔGas-7 or ΔGss-6or both
Energy criteria >= -3.2 >= -6.6 >= -7.0
P value of Chi-test 0.0046 0.0005 0.0045 0.0000001
True positive 155 155 115 192
False positive 35 32 22 39
True negative 33 36 46 29
False negative 66 66 106 29
ROC specificity 0.49 0.53 0.68 0.43
ROC sensitivity 0.70 0.70 0.52 0.87
ROC: Receiver Opearting Characteristic. True positives (TP) are those shRNAs which are experimentally tested to be functional and they meet the 
energy criteria. False positives (FP) are those shRNAs which meet the energy criteria but are experimentally tested to be nonfunctional. True 
negatives (TN) are those which are nonfunctional in experiments and fail the energy criteria. False negatives (FN) are those which fail the energy 
criteria but are functional experimentally. ROC specificity = TN/(TN+FP); ROC sensitivity = TP/(TP+FN).
Table 3: Sequence characteristics that consistently show either 
positive or negative impacts on shRNA efficacy in Least Square 
Analysis.
Positive Parameters
Parameter Position Coefficient
G3 8 . 0 1
G5 9 . 1 1
A 11 7.59
T 14 6.16
CA 6–7 11.48
CC 8–9 11.63
TG 10–11 19.58
GA 13–14 31.32
TA 17–18 6.36
TA 18–19 24.11
Negative Parameters
Parameter Position Coefficient
TA 4–5 -35.04
TA 6–7 -23.35
GG 8–9 -21.00
GC 9–10 -24.66
GA 17–18 -15.08BMC Genomics 2009, 10(Suppl 1):S9 http://www.biomedcentral.com/1471-2164/10/S1/S9
Page 5 of 7
(page number not for citation purposes)
difference is 0.00034. This might indicate that longer
sequence characteristics affect shRNA efficacy more than
shorter sequence characteristics.
As there are reports that local RNA target structure influ-
ences siRNA efficacy [26,27], we then wanted to know if
this could happen to shRNA. The secondary structure of
mRNA could be formed for various reasons, but internal
palindromes and repeated sequences are two causes in
some cases. Please be aware that here we only performed
the analysis statistically. The result does not indicate how
much the secondary structure could impact the shRNA
efficacy.
Initially we considered all possible palindromes and
repeated sequences of length 7 or more that could involve
any part of the 21 shRNA nucleotides. No significant
results were found. We then only considered the possible
palindromes and repeated sequences of length 8 or more
that could only involve any part of the 6 base pairs from
5' terminal or of the 7 base pairs from 3' terminal. It was
found that the number of possible palindromes of length
8 or more involving 3' terminal shows statistical bias
between functional and nonfunctional shRNAs. Nonfunc-
tional shRNAs tend to have more possible palindromes.
This bias is most significant with palindromes of length 9
or more involving any part of the 7 base pairs from the 3'
terminal. By Chi-Square test, the statistical significance is
p = 0.011 with removal range of 55–80% and p = 0.0001
with removal range of 60–75%. Please notice that here we
assumed that more possible palindromes implies higher
probabilities for the terminal to be involved in secondary
structure formation. If the assumption is valid, then the
above result implies that secondary structure involving
the 3' terminal could negatively impact the shRNA effi-
cacy.
The above experiment targets the 7 base pairs at the 3' ter-
minal. It is reasonable again to ask if other lengths of
nucleotide sequences at 3' terminal will show similar sta-
tistical bias. Unsurprisingly, we found that all 3' terminal
sequences of lengths 1 to 7 show similar statistical bias,
i.e. functional shRNAs tend to have less possibility for all
the terminal sequences of lengths 1 – 7 to be involved in
palindrome formation. The most statistical bias is found
with terminal sequence of length 6 (p < 0.000004 with
removal range of 60–75%, p = 0.0006 with removal range
55–80%). This discovery motivates us to combine it with
energy profile in order to further improve the efficacy
predication. Our investigation has yet to show that this
statistical bias could further improve the predication accu-
racy. This is not surprising since the possible palindrome
structure could affect the terminal energy state. The two
variables, the terminal energy state and the possible sec-
ondary structure are interfering with each other. A multi-
variate statistical analysis or recursive partition approach
might help bring more lights into our future investigation.
Conclusion
The default setting of the three-phase algorithm is rela-
tively stringent. Under this default setting, the algorithm
cannot design shRNA sequences for approximately 8% of
genes from human Refseq database [23]. It is possible that
many functional shRNA sequences are missed by this
algorithm. However, when there could be enough shRNA
sequences designed for a given gene, this algorithm with
the default stringent setting promises a good probability
for functional shRNAs.
It has been confirmed by several studies that the free
energy profile at the two terminals is the most critical fac-
tor relating to siRNA efficacy [7,15-20]. Our analysis on
shRNA dataset confirms that this belief applies to shRNA
design. However, there is difference. For chemically syn-
thesized siRNA, it was first found that the high free energy
of first 5 base pairs at each terminal correlated well with
siRNA efficacy [12,25], and later other researchers discov-
ered that it might be the high free energy of the first 2 base
pairs [19,20]. Our results show that shRNA efficacy can be
predicted more effectively using the free energy profile of
the first 6 base pairs at the 5' terminal and the first 7 base
pairs at the 3' terminal. Currently we are not clear about
the reason behind the difference, though the difference
might be due to the differences between chemically syn-
thesized siRNA and shRNA.
Internal palindrome is one of several causes that help
RNA molecules form secondary structures. Our analysis
found that shRNAs with more possible palindromes
involving the 3' terminal tend to affect shRNA efficacy
negatively, especially those possible palindromes that are
of length 9 or more and involve the 7 terminal nucle-
otides. RNA secondary structure involving the terminal
could limit the accessibility of the terminal, which might
explain why the secondary structure could negatively
impact shRNA efficacy. However, our result is very primi-
tive since it is obtained with possible palindromes only
and is only a statistical analysis result. Our future work
will make use of software mfold to more precisely eluci-
date the relationship between shRNA efficacy and RNA
secondary structure. If more positive relationships are
found, confirmation by biological experiments will fol-
low.
Methods
Cell culture and shRNA delivery
293H cells (Invitrogen) were cultured in D-MEM supple-
mented with 10% FBS and 1× non-essential amino acids
(Invitrogen) for no more than 15 passages. Gene specific
shRNA sequences were designed using the three-phaseBMC Genomics 2009, 10(Suppl 1):S9 http://www.biomedcentral.com/1471-2164/10/S1/S9
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algorithm [23]. Negative control is a shRNA that has a ran-
dom sequence and no homology to the mammalian tran-
scriptome. All shRNAs were cloned into the pGeneClip™
hMGFP vector (Promega) to generate SABioscience Sure-
Silencing™ shRNA plasmids. Transfection grade SureSi-
lencing™ plasmid (0.8 mg) mixed with Lipofectamine
2000 reagent (Invitrogen, 3 mL) was delivered to 80,000
cells in a 24-well plate format. Culture media were
changed 24 hours after transfection. Transfection effi-
ciency was estimated by following the expression of GFP
using fluorescence microscopy. After 48 hours, total RNA
was extracted using the ArrayGrade™ Total RNA Isolation
Kit with gDNA cleanup by TURBO DNase™ (Ambion).
Real-time RT-PCR
cDNA was synthesized from total RNA using the Reaction-
Ready™ First Strand cDNA Synthesis Kit. Real-time PCR
was performed using RT2 SYBR Green qPCR Master Mixes
on the Bio-Rad iCycler real-time PCR system or the Strat-
agene Mx3000 realtime PCR system.
Gene knockdown efficiency calculation
Detailed description of knockdown success rate and its
calculation is given in [28]. Real-time RT-PCR method
was chosen to measure the relative mRNA levels between
cells (293H from Invitrogen) transfected with a negative
control shRNA and the cells transfected with target-spe-
cific shRNA. The percentage knockdown of a gene was cal-
culated using the ΔΔCt method [29]. Basically, the
expression level of our gene of interest is normalized to an
internal control gene (GAPDH here) to obtain the ΔCt
value, before it is compared between two differentially
treated cells (thus the ΔΔCt). Since this validation process
is complex, involving many different steps, we have built
a statistical model to capture all the variations in the
whole process [28]. By this model, we can mature the 95%
confidence interval (CI) of the percentage knockdowns of
any given shRNA. So our definition of a "successful"
design is the shRNA that has a mean knockdown (KD)
above 70%, with a lower bound of KD above 55.5% (with
95% CI). Please notice that all experiments were repeated
for three times, and only those experiments with transfec-
tion efficiency greater than 80% and good PCR replicate
consistency were included for analysis.
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